BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3117995)

  • 1. Immunohistochemical localization of apolipoproteins A-I and B in human carotid arteries.
    Carter RS; Siegel RJ; Chai AU; Fishbein MC
    J Pathol; 1987 Sep; 153(1):31-6. PubMed ID: 3117995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of apolipoprotein B in human atherosclerotic lesions.
    Yomantas S; Elner VM; Schaffner T; Wissler RW
    Arch Pathol Lab Med; 1984 May; 108(5):374-8. PubMed ID: 6370192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of apolipoprotein A-I and B-100 in canine atherosclerotic lesions.
    Sako T; Uchida E; Kagawa Y; Hirayama K; Nakade T; Taniyama H
    Vet Pathol; 2003 May; 40(3):328-31. PubMed ID: 12724575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B localization in coronary atherosclerotic plaques from cynomolgus monkeys.
    Hoff HF; Bond MG
    Artery; 1983; 12(2):104-16. PubMed ID: 6380455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal biosynthesis of apolipoproteins during active fat absorption in rabbits.
    Bergmann S; Jaross W; Klimov AN; Denisenko AD
    Biomed Biochim Acta; 1984; 43(4):457-62. PubMed ID: 6435608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries.
    Bedossa P; Poynard T; Abella A; Paraf F; Lemaigre G; Martin E
    Arch Pathol Lab Med; 1989 Jul; 113(7):777-80. PubMed ID: 2742459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the association of intracellular apolipoprotein (a) with apolipoprotein B in human liver.
    Higgins JA; Munro LH; Wilkinson J
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():41-3. PubMed ID: 8767457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-localization of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis.
    Galis ZS; Alavi MZ; Moore S
    Am J Pathol; 1993 May; 142(5):1432-8. PubMed ID: 8494047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immuno-morphologic detection of specific APO-B antigenic determinants in normal intima and atherosclerotic plaques in the human aorta].
    Shekhonin BV; Tararak EM; Kovaleva EA; Ianushevskaia EV; Trakht IN
    Arkh Patol; 1989; 51(2):23-30. PubMed ID: 2469412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages.
    Lin KY; Chen YL; Shih CC; Pan JP; Chan WE; Chiang AN
    J Cell Biochem; 2002; 86(2):258-67. PubMed ID: 12111995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B accumulation and development of foam cell lesions in coronary arteries of hypercholesterolemic swine.
    Yamauchi Y; Hoff HF
    Lab Invest; 1984 Sep; 51(3):325-32. PubMed ID: 6381881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipids, apolipoproteins A and B in maternal and umbilical vessels in term pregnancies.
    Ramón y Cajal J; Pocoví M; Jiménez D; Romero MA; de Agüero RG; Martinez H; Grande F
    Artery; 1985; 13(1):32-40. PubMed ID: 4062573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of monoclonal antibodies to the assay of apolipoproteins].
    Marcel YL; Weech PK; Milne RW
    Ann Biol Clin (Paris); 1986; 44(5):536-44. PubMed ID: 2433973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interaction of the extracellular matrix protein DANCE with apolipoprotein(a) mediated by the kringle IV-type 2 domain.
    Kapetanopoulos A; Fresser F; Millonig G; Shaul Y; Baier G; Utermann G
    Mol Genet Genomics; 2002 Jun; 267(4):440-6. PubMed ID: 12111551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein localization and quantitation in the human intestine.
    Green PH; Lefkowitch JH; Glickman RM; Riley JW; Quinet E; Blum CB
    Gastroenterology; 1982 Dec; 83(6):1223-30. PubMed ID: 6813184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.
    Marcovina S; Packard CJ
    J Intern Med; 2006 May; 259(5):437-46. PubMed ID: 16629849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.